Pharmaron Beijing Co., Ltd. (SHE:300759)
30.72
+1.76 (6.08%)
Aug 13, 2025, 2:45 PM CST
Accolade Revenue
Pharmaron Beijing had revenue of 3.10B CNY in the quarter ending March 31, 2025, with 16.03% growth. This brings the company's revenue in the last twelve months to 12.70B, up 10.61% year-over-year. In the year 2024, Pharmaron Beijing had annual revenue of 12.28B with 6.39% growth.
Revenue (ttm)
12.70B
Revenue Growth
+10.61%
P/S Ratio
4.06
Revenue / Employee
594.47K
Employees
21,370
Market Cap
51.52B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 12.28B | 737.78M | 6.39% |
Dec 31, 2023 | 11.54B | 1.27B | 12.39% |
Jan 1, 2023 | 10.27B | 2.82B | 37.92% |
Dec 31, 2021 | 7.44B | 2.31B | 45.00% |
Dec 31, 2020 | 5.13B | 1.38B | 36.64% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 41.48B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |